These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2819921)

  • 41. Some pharmacological properties of the polyamines spermine and spermidine--a re-appraisal.
    Shaw GG
    Arch Int Pharmacodyn Ther; 1972; 198(1):36-48. PubMed ID: 4115410
    [No Abstract]   [Full Text] [Related]  

  • 42. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of apomorphine-induced behaviour following chronic swim exercise in rats.
    Dey S; Singh RH
    Neuroreport; 1992 Jun; 3(6):497-500. PubMed ID: 1391756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior.
    Kelley AE; Gauthier AM; Lang CG
    Behav Brain Res; 1989 Oct; 35(1):27-39. PubMed ID: 2803542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R; Schmidt D; Leith N
    Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. REM sleep deprivation decreases apomorphine-induced stimulation of locomotor activity but not stereotyped behavior in mice.
    Asakura W; Matsumoto K; Ohta H; Watanabe H
    Gen Pharmacol; 1992 May; 23(3):337-41. PubMed ID: 1511844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine receptors in the striatum and limbic system of various strains of mice: relation to differences in responses to apomorphine.
    Michaluk J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Sansone M; Oliverio A; Vetulani J
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1115-8. PubMed ID: 6891791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum.
    Martin-Iverson MT; Radke JM; Vincent SR
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1707-14. PubMed ID: 2874568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of polyamines on the uptake of neurotransmitters by rat brain synaptosomes.
    Law CL; Wong PC; Fong WF
    J Neurochem; 1984 Mar; 42(3):870-2. PubMed ID: 6141227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
    Fields JZ; Wichlinski L; Drucker GE; Engh K; Gordon JH
    Pharmacol Biochem Behav; 1991 Dec; 40(4):881-6. PubMed ID: 1816575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions.
    Starr MS; Summerhayes M
    Neuroscience; 1983 Dec; 10(4):1171-83. PubMed ID: 6320047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy.
    Carter CJ; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):51-4. PubMed ID: 573866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE
    Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.